Principal Site Activation Manager

Summary

Syneos Health is a leading fully integrated biopharmaceutical solutions organization that accelerates customer success by translating unique clinical, medical affairs, and commercial insights into tangible outcomes. The company provides comprehensive clinical development services spanning Phase I to Phase IV trials, including full-service global studies, clinical monitoring, patient recruitment, investigator recruitment, and data management. Additionally, Syneos Health offers commercial solutions such as communications, medication adherence programs, and consulting services. With over 26,000 employees worldwide, including more than 480 MDs and 750 PhDs, the organization supports biopharmaceutical companies across all stages of drug development and commercialization. Syneos Health has helped develop or commercialize 93% of novel drugs approved by the FDA and 90% of products granted marketing authorization by the EMA in the last five years, demonstrating its significant impact on bringing important therapies to patients globally.

Job description

Requirements

• Lead and oversee global site activation activities from study start-up through site readiness
• Develop and execute country and site activation strategies
• Manage timelines, risks, and deliverables across multiple studies or programs
• Partner closely with Clinical Operations, Regulatory Affairs, Contracts & Budgets, and external stakeholders
• Drive performance metrics and ensure activation milestones are achieved
• Provide guidance and oversight to Site Activation Managers and study teams
• Support issue escalation and resolution for complex start-up challenges
• Ensure compliance with regulatory requirements, SOPs, and sponsor expectations

Benefits

• Company Car Or Car Allowance
• Medical Insurance
• Dental Insurance
• Vision Insurance
• 401(k) Company Match
• Employee Stock Purchase Plan
• Commission Or Bonus Eligibility
• Flexible Paid Time Off
• Sick Time

Company overview

Syneos Health is a leading fully integrated biopharmaceutical solutions organization that accelerates customer success by translating unique clinical, medical affairs, and commercial insights into tangible outcomes. The company provides comprehensive clinical development services spanning Phase I to Phase IV trials, including full-service global studies, clinical monitoring, patient recruitment, investigator recruitment, and data management. Additionally, Syneos Health offers commercial solutions such as communications, medication adherence programs, and consulting services. With over 26,000 employees worldwide, including more than 480 MDs and 750 PhDs, the organization supports biopharmaceutical companies across all stages of drug development and commercialization. Syneos Health has helped develop or commercialize 93% of novel drugs approved by the FDA and 90% of products granted marketing authorization by the EMA in the last five years, demonstrating its significant impact on bringing important therapies to patients globally.